Skip to content
Screener

Insmed INSM Reportable Segment — Depreciation

Similar metrics at other companies

Open Text logo
OTEXReportable Segment — Depreciation
$35.98M+10.2%
Ametek logo
AMEEIG — Depreciation
$19.18M+2.2%
Ametek logo
AMEEMG — Depreciation
$15.45M+0.3%
SEI Investments logo
SEICInstitutional Investors — Depreciation
$455K-7.9%
SEI Investments logo
SEICInvestment Advisors — Depreciation
$1.67M-16.6%
SEI Investments logo
SEICInvestment Managers — Depreciation
$1.8M+3.6%

Other financials

Income statement

See full
Revenue$425.5M+296%
Gross profit$358.3M+352%
Operating income-$1.5M+99.5%
Net income-$13.2M+95.9%
EPS (diluted)-$0.06+96.5%

Balance sheet

See full
Cash & equivalents$544.8M-57.6%
Total debt$579.9M+0.8%
Total equity$757.5M-39.4%
Total assets$2.1B-15.2%

Cash flow

See full
Operating cash flow-$88.8M+56.8%
CapEx$6.3M+79.6%
Free cash flow-$95.1M+54.5%

Valuation

See full
Market cap$21.46B+1.6%
Enterprise value$21.5B+5.3%
P/S18.9×-34.2×

Profitability

See full
Gross margin83.5%+7.7pp
Operating margin-73.9%-30.6pp
Net margin-76.9%-31.8pp
FCF margin-71%-28.6pp

Returns & leverage

See full
Return on equity-87.2%-27.3pp
Debt / equity0.8×+0.3×
Current ratio3.7×-3.0×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:DepreciationNonproduction.

The source filing: Insmed’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104506-26-000041
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
R&D compensation and benefit-related expenses69,08056,389141,220109,947
SG&A compensation and benefit-related expenses70,52051,320145,313106,156
Other segment items(a)207,425127,650417,913247,345
Depreciation3,1792,4846,1134,367
Amortization of intangible assets2,0811,2634,1622,526
Change in fair value of contingent consideration(99,760)59,000(146,721)77,300
Investment income(10,979)(13,225)(23,019)(27,131)
Interest expense20,27321,24540,35542,814

Item 1C. Consolidated Financial Statements

FAQ

What is Insmed's reportable segment — depreciation?
Insmed (INSM) reported reportable segment — depreciation of $3.18M in Q2 2026.
How has Insmed's reportable segment — depreciation changed year-over-year?
Insmed's reportable segment — depreciation increased by 28.0% year-over-year, from $2.48M to $3.18M.
What is the long-term trend for Insmed's reportable segment — depreciation?
Over 3 years (2022 to 2025), Insmed's reportable segment — depreciation has grown at a 25.6% compound annual growth rate (CAGR), from $5.28M to $10.45M.
What does reportable segment — depreciation mean?
This represents the systematic allocation of the cost of tangible assets over their useful lives within the segment. It is a non-cash expense reflecting the wear and tear of physical infrastructure.

Ask your AI about Insmed's reportable segment — depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude